These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 2181563)

  • 1. [Post-surgical adjuvant treatment of breast cancer].
    Román JM; Martín M
    Rev Clin Esp; 1990 Jan; 186(1):1-4. PubMed ID: 2181563
    [No Abstract]   [Full Text] [Related]  

  • 2. [Medical treatment of breast carcinoma].
    Rosso R; Gardin G
    Ann Ital Chir; 1991; 62(5):467-77. PubMed ID: 1801625
    [No Abstract]   [Full Text] [Related]  

  • 3. Randomized clinical trials in breast cancer: a tabular summary. Part 1: Primary breast cancer.
    Conrad B; Kieser R
    Arch Geschwulstforsch; 1986; 56(3):211-36. PubMed ID: 3524501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Have therapeutic measures improved the prognosis of operable breast cancer? Adjuvant chemotherapy].
    Senn HJ
    Verh Dtsch Ges Inn Med; 1985; 91():421-8. PubMed ID: 4090642
    [No Abstract]   [Full Text] [Related]  

  • 5. [Adjuvant therapy of breast cancer].
    Semiglazov VF; Abzumanov AS; Bozhok AA; Ivanov VG; Ivanova OA; Barash NIu; Topuzov EE; Seleznev IK; Migmanova NSh; Popova RT; Nurgaziev KSh
    Khirurgiia (Mosk); 2001; (5):52-60. PubMed ID: 11505673
    [No Abstract]   [Full Text] [Related]  

  • 6. [Adjuvant chemo and hormone therapy in breast cancer].
    Sauer H; Wilmanns W
    Chirurg; 1984 Apr; 55(4):207-10. PubMed ID: 6547086
    [No Abstract]   [Full Text] [Related]  

  • 7. Post-operative therapy of breast cancer: rationale for adjuvant chemotherapy.
    Butler WM
    J S C Med Assoc; 1984 Jan; 80(1):15-6. PubMed ID: 6371378
    [No Abstract]   [Full Text] [Related]  

  • 8. Adjuvant systemic therapy for early breast cancer: progress and controversies.
    Hortobagyi GN
    Clin Cancer Res; 2001 Jul; 7(7):1839-42. PubMed ID: 11448893
    [No Abstract]   [Full Text] [Related]  

  • 9. Adjuvant systemic therapy of breast cancer.
    Lippman ME
    Important Adv Oncol; 1985; ():254-72. PubMed ID: 3916744
    [No Abstract]   [Full Text] [Related]  

  • 10. Primary chemotherapy in surgically resectable breast cancer: the experience of the Milan Cancer Institute.
    Valagussa P; Bonadonna G
    Zentralbl Gynakol; 1996; 118(10):571. PubMed ID: 8912477
    [No Abstract]   [Full Text] [Related]  

  • 11. [Timing of radiotherapy in the treatment of breast carcinoma. Review of the literature].
    Trovò MG; Gigante M; Roncadin M; Arcicasa M; Bortolus R
    Ann Ital Chir; 1999; 70(3):371-6. PubMed ID: 10466240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prevention of infection and improvement of cenesthesia with thymostimulin during chemotherapy following mastectomy].
    Alba E; Visentin L; Farina C; Wierdis T
    Minerva Ginecol; 1991 Dec; 43(12):585-7. PubMed ID: 1819777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mastectomy followed by cytoreductive chemotherapy in locally advanced breast cancer.
    Pluzańska A; Berner J; Dowgier-Witczak I; Malecka E; Pawlowski R; Wrezel E; Jeziorski A; Kamińska A; Tenderenda M
    J Chemother; 1989 Jul; 1(4 Suppl):1186-8. PubMed ID: 16312827
    [No Abstract]   [Full Text] [Related]  

  • 14. [The differences of standard therapy for breast cancer between Europe/America and Japan--chemotherapy, operation,and radiotherapy].
    Kitagawa D; Saji S
    Gan To Kagaku Ryoho; 2007 May; 34(5):690-3. PubMed ID: 17496438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Improvement of survival due to adjuvant therapy in patients with operable breast carcinoma].
    Repelaer van Driel OJ; Welvaart K; Stijnen T
    Ned Tijdschr Geneeskd; 1986 Apr; 130(16):744-6. PubMed ID: 3713882
    [No Abstract]   [Full Text] [Related]  

  • 16. Intensive multi-drug post-operative chemotherapy for high risk stage II breast cancer.
    Shetty PA; D'Souza LJ; Shinde SR; Jussawalla DJ
    Indian J Cancer; 1983; 20(4):211-4. PubMed ID: 6676170
    [No Abstract]   [Full Text] [Related]  

  • 17. [Intensive chemotherapy in day hospitals].
    Farnault G
    Soins Gynecol Obstet Pueric Pediatr; 1985 Mar; (46):45-8. PubMed ID: 3847184
    [No Abstract]   [Full Text] [Related]  

  • 18. Patterns of locoregional failure in patients with operable breast cancer treated by mastectomy and adjuvant chemotherapy with or without tamoxifen and without radiotherapy: results from five National Surgical Adjuvant Breast and Bowel Project randomized clinical trials.
    Taghian A; Jeong JH; Mamounas E; Anderson S; Bryant J; Deutsch M; Wolmark N
    J Clin Oncol; 2004 Nov; 22(21):4247-54. PubMed ID: 15452182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low locoregional recurrence rate among node-negative breast cancer patients with tumors 5 cm or larger treated by mastectomy, with or without adjuvant systemic therapy and without radiotherapy: results from five national surgical adjuvant breast and bowel project randomized clinical trials.
    Taghian AG; Jeong JH; Mamounas EP; Parda DS; Deutsch M; Costantino JP; Wolmark N
    J Clin Oncol; 2006 Aug; 24(24):3927-32. PubMed ID: 16921044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiotherapy and chemotherapy in high-risk breast cancer.
    Goldhirsch A; Coates AS; Colleoni M; Gelber RD
    N Engl J Med; 1998 Jan; 338(5):330-1; author reply 331-2. PubMed ID: 9446031
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.